DURHAM, N.C.--(BUSINESS WIRE)--CED, the Southeast’s largest entrepreneurial support organization, today announced the agenda and speakers for the CED Life Science Conference 2013, February 27-28, 2013, in Raleigh, North Carolina. The North Carolina Biotechnology Center and North Carolina Biosciences (NCBIO) are presenting partners.
“We have secured an impressive lineup of opinion leaders, who will speak to the critical challenges and opportunities that lie ahead.”
The keynote speakers at the CED Life Science Conference 2013 are N. Anthony (Tony) Coles, M.D., chairman and CEO, Onyx Pharmaceuticals, Inc.; Dr. Samuel Nussbaum, M.D., executive vice president, Clinical Health Policy and chief medical officer, WellPoint, Inc.; and Jack W. Szostak, Ph.D., recipient of the 2009 Nobel Prize in physiology or medicine, investigator, Howard Hughes Medical Institute, and professor of genetics, Harvard Medical School.
The conference co-chairs are David P. King, CEO, LabCorp; Ed Mathers, partner, NEA; and Bradley Wilson, president and CEO, Blue Cross and Blue Shield of North Carolina. The CED Life Science Conference attracts more than 1,000 life science entrepreneurs, investors and industry professionals.
Early registration discounts are available through January 25, 2013. To register or view the full conference agenda, visit the CED Life Science Conference 2013 site at http://www.cednc.org/lifescience.
“This conference is a must-attend event for those in the life science industry,” said David King, CEO of LabCorp, who will lead a panel on leadership. “We have secured an impressive lineup of opinion leaders, who will speak to the critical challenges and opportunities that lie ahead.”
“The conference represents the largest regional gathering of the life science community,” said CED president Joan Siefert Rose. “This year’s program includes a showcase of up-and-coming companies, updates on policy affecting the industry, and excellent opportunities for high-level networking,” Rose said. The conference is now in its 22nd year.
CED’s mission is to identify, enable and promote emerging growth companies and to accelerate the entrepreneurial culture of the Research Triangle and North Carolina.
About NC Biotechnology Center
The Biotechnology Center is a private, non-profit corporation supported by the N.C. General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business, education and strategic policy statewide.
NCBIO is dedicated to promoting the future growth and development of North Carolina’s bioscience industry. NCBIO advocates for state and federal public policies that encourage the growth of life science companies, support the development of a strong life science workforce, and promote research and technology transfer at universities and other institutions.